The spiral ganglion neurons (SGN) provide the afferent innervation of the hair cells in the organ or Corti and relay auditory information from the inner ear to the brain. Voltage-gated sodium channels (Na V ) initiate and propagate action potentials that encode this sensory information but little is known regarding the subtypes expressed in these cells. We have used RT-PCR and immunohistochemistry to study the compliment and anatomical distribution of Na V channels in rodent SGN. Na V 1.1, Na V 1.6 and Na V 1.7 were all detected at the mRNA level. Fluorescence or streptavidin-horseradish peroxidase immunohistochemistry extended these findings, demonstrating predominant localisation of Na V 1.6 and Na V 1.7 on SGN cell bodies and Na V 1.1 on axonal processes. Dual labelling with peripherin demonstrated higher Na V 1.6 and Na V 1.7 expression on Type I, rather than Type II neurons. These results provide evidence for selective expression and variations in the distribution of VGSC in the rodent SGN, which may guide further studies into afferent function in the auditory pathway and therapeutic approaches for diseases such as hearing loss and tinnitus.
Introduction
There are nine recognised members of the voltage-gated sodium channel family (VGSC; Na V 1.1-1.9). Of these Na V 1.1, 1.2, 1.3, and 1.6 are highly (but not exclusively) expressed in the central nervous system whereas Na V 1.7, 1.8 and 1.9 demonstrate a more restricted expression pattern, in autonomic and sensory neurons in the peripheral nervous system , and Na V 1.4 and Na V 1.5 represent the predominant skeletal muscle and cardiac sodium channels, respectively . The Na V 1.6 sub-type is also highly expressed in the peripheral nervous system where it is enriched at the nodes of Ranvier of myelinated axons and contributes to saltatory conduction .
The spontaneously active spiral ganglion neurons (SGN) form the afferent conduction pathway in the auditory periphery. There are two types of SGN, Type I neurons that innervate the inner hair cells and Type II neurons that innervate the outer hair cells . The conduction of nerve impulses along these afferents is controlled by a number of ion channels including the voltage-gated sodium channels. Clearly, establishing the expression and distribution of the sodium channels expressed in the auditory periphery could impact our understanding of action potential dynamics and coding of auditory stimuli as well as normal and abnormal phenotypes . This knowledge would also contribute to the development of putative therapeutics for disorders such as tinnitus, enabling more precise targeting of channels involved in tinnitogenesis and, potentially provide opportunities for the rational development of sub-type selective ligands to address this area of unmet need . To date, only one study has been reported that has examined VGSC expression and distribution in SGN but this was limited to Na V 1.2, and Na V 1.6. The aim of this study, therefore, was to fully characterise the expression and distribution pattern of relevant VGSCs using RT-PCR and Na V subtype selective antibodies in rat SGN.
Results

Na V alpha subunit expression using RT-PCR
Validation of primer specificity in Rat cerebral cortex and DRG:
To confirm the specificity of the primers used, tissue with previously documented Na V α subunit expression were utilised. Distinct bands at the correct predicted sizes were observed for Na V 1.1, Na V 1.2, Na V 1.3 and Na V 1.6 in the cerebral cortex, with weak bands present for Na V 1.7 and Na V 1.9 (Fig. 1A) . With the mRNA isolated from the rat DRG, distinct bands were seen for Na V 1.1, Na V 1.7, Na V 1.8 and Na V 1.9 while a weak band was observed for Na V 1.6 (Fig. 1B) .
Rat spiral ganglion:
The RT-PCR primers specific for the Na V α subunits and β-actin were used to probe the cDNA created from mRNA isolated from rat modioli homogenates. Distinct bands at the correct predicted molecular weight were observed for Na V 1.7, Na V 1.6 and Na V 1.1, as well as the control gene β-actin (Fig. 1C) . No bands were seen in the lane without reverse transcription, showing that there was no genomic DNA contamination.
Immunocytochemical localization of Na V alpha subunits in spiral ganglion neurons Na V 1.7: The Na V 1.7 antibody strongly labelled the cell bodies of rat SGN using fluorescently tagged secondary antibodies ( Fig.2A and B) . Labelling was found throughout the cytoplasm of the cell body, with no clear differentiation between membrane and cytoplasmic labelling.
Variation was observed in the intensity of labelling, with some neurons strongly labelled and others only faintly labelled (Fig. 2B ).
In sections of rat cochlea incubated without the primary antibody, the labelling was reduced to background levels although pale yellow puncta were noted throughout the cytoplasm (Fig.   2C ).
To demonstrate that this punctate labelling was due to non-specific fluorescence, experiments were repeated using the same Na V 1.7 antibody but with streptavidin/horseradish peroxidase (HRP) and DAB to non-fluorescently visualise the primary antibody binding. Using this method, the SGN were positively labelled with brown reaction product as seen in Figs 2D and E. The positively labelled SGN cell bodies showed variation in staining intensity, similar in appearance to that observed in the fluorescence imaging technique. Additionally, the sections of rat cochlea incubated without the primary antibody did not show neurons labelled with the brown reaction product, nor the punctate labelling observed in the previous controls using fluorescently tagged antibodies (Fig. 2F ). This confirmed that the puncta could be considered as tissue autofluorescence.
Na V 1.6: The Na V 1.6 antibody strongly labelled the cell bodies of rat SGN ( Fig. 3A and B ).
The pattern of distribution was similar to that seen with the Na V 1.7 antibody. Labelling was found throughout the cytoplasm of the cell body, with no clear differentiation between membrane and cytoplasmic labelling. Additionally, there was again considerable variation observed in the intensity of neuronal labelling as seen in Fig. 3B . In contrast to the labelling seen with Na V 1.7, peripheral and central processes were also strongly labelled for Na V 1.6 α-subunits As performed previously, sections of rat cochlea incubated without the primary antibody the labelling was reduced to background levels, although pale yellow autofluorescent puncta were observed throughout the cytoplasm as were also seen for Na V 1.7 (Fig. 3C) . As for Na V 1.7, this punctate labelling was demonstrated as non specific by using the HRP/DAB method to visualise non-fluorescently primary antibody binding. The SGN were positively stained for Na V 1.6 with the brown reaction product using this method as seen in Figs 3D and E. Again, positively labelled SGN cell bodies showed variation in staining intensity similar in appearance to that seen with fluorescence imaging. The distinct staining of the neuronal processes was replicated and, in addition, staining of the cell body membranes was observed (Fig. 3E) . Sections of rat cochlea incubated without the primary antibody did not show neurons labelled with the brown reaction product nor the punctate labelling observed in the previous fluorescence controls (Fig. 3F) . Na V 1.1: The Na V 1.1 antibody weakly stained the SG neurons and was only detectable using the non-fluorescent HRP/DAB method as seen in Figure 4 . Weak staining was observed in the SGN cell bodies while darker staining was seen in the neuronal processes, specifically in the axons (Fig 4A and B) . The sections of rat cochlea incubated without the primary antibody did not show labelled neurons (Fig. 4C ).
Peripherin labelling of spiral ganglion neurons
It has been previously reported that antibodies generated against the intermediate filament protein, peripherin, preferentially label Type II SGN in sections of cochlea . A small proportion (33/242 or 14%) of SGN were labelled by this antibody. Most noticeably, all the labelled neurons appeared to be smaller compared to the unlabelled neurons (Fig. 5A ).
Peripherin labelling status and Na V 1.7: The relationship between cell body area and peripherin labelling status was investigated further by dual labelling sections of cochlea with peripherin and Na V 1.7 antibodies. This was performed using sections from four cochleae ( Fig   5A and B) . The frequency histogram of cell body area in Fig. 5C shows that distribution in peripherin positive neurons was distinctly separate from that of peripherin negative neurons. This represents about a two-fold difference in cell body area.
On visual inspection of the sections it appeared that the peripherin positive neurons were labelled less intensely by the Na V 1.7 antibody than the peripherin negative neurons. To investigate the relationship between peripherin and density of Na V 1.7 labelling further, the average fluorescence intensity of the neurons labelled with the Na V 1.7 antibody and peripherin negative and positive neurons was measured in four cochleae.
The mean Na V 1.7 fluorescence was significantly different between the peripherin negative and positive neurons, from 120.1±1.4 vs 100.2±3.7 respectively at p<0.01. This confirmed the impression of differences in staining intensity between the two groups. Combination of these two parameters in a scatter plot of cell body area versus average fluorescence in Fig 5E, further illustrates that peripherin negative neurons possess larger cell body areas and label more strongly with Na V 1.7 antibody.
Peripherin labelling status and Na V 1.6: An identical set of dual labelling experiments to those with Na V 1.7 were performed, using peripherin and Na V 1.6 antibodies and sections from the same rat cochleae that were used previously. Similar initial observations and results with regards to antibody staining, cell body area and fluorescence intensity were obtained as shown in Figs 6 A-E. With Na V 1.6 the difference in distribution and means of cell body area between peripherin negative and positive was more marked than for Na V 1.7. The differences in mean cell body area were significantly different with means of 185.7±2.2µm 2 (n=203) vs 74.8±3.2µm 2 (n=34) respectively, p <0.001, or about a 2.5 fold difference in cell body area.
Differences in mean Na V 1.6 fluorescence between the negative and positive stained peripherin neurons were also significantly different, with mean difference of about 40 units;
142.6±1.7 (n=203) vs 101.6±3.2 (n=34) respectively, p <0.001.
Combination of the two parameters in a scatter plot of cell body area versus average fluorescence in Fig 5E , further illustrates that peripherin negative neurons label more intensely than with Na V 1.6 antibody.
Comparison of Na V 1.6 and Na V 1.7 SGN labelling: Direct comparison of Na V 1.6 and Na V 1.7
immunofluorescence values was not justified as the relative antibody binding affinities were not known. However, SGN cell body area could be compared directly. The Type I means of 185.7±2.2µm 2 vs 165.3 µm 2 ±1.8µm 2 for Na V 1.6 and Na V 1.7 respectively, were highly significantly different at p <0.001. The respective difference in Type II means, 74.8±3.2µm 2 vs 82.2 µm 2 ±2.6, for Na V 1.6 and Na V 1.7 was not significant at p>0.05.
Peripherin labelling status and Na V 1.1: Dual labelling experiments with peripherin and Na V 1.1 antibodies could not be performed because of the weak labelling of the SGN cell bodies using Na V 1.1 antibodies.
Discussion
Rat SGN exhibits a unique pattern of Na V subunit expression: The results presented here provide for the first time strong evidence that the α-subunits, Na V 1.7, Na V 1.6 and Na V 1.1, are selectively expressed in adult rat SGNs. There are a number of unusual features in this pattern of Na V subunit expression, as they suggest that expression in the SGN does not follow that observed in either the central or peripheral nervous system. Instead, the results presented here
show Na V isoforms normally considered to be specific to the peripheral and central nervous system are both expressed in the SGN. The explanation for this may be related to the independent embryological origins of the SGN . The peripheral and central nervous systems are known to arise from different progenitor cells in the developing embryo. The CNS forms from the dorsal ectoderm through envagination and formation of the neural tube. DRG neurons arise from neural crest cells that migrate laterally to form the peripheral ganglia (Kuan et al., 2004, Li, Say and . In contrast, the SGN develops from a distinct region of neural ectoderm known as the otic placode, which is separate from both the neural tube and neural crest cells (Holley, 2005, Fekete and . The results from this study suggest that the otic placode displays an intermediate phenotype with regard to Na V channel expression between the CNS and PNS.
Na V 1.1 subunit expression: Na V 1.1 has been previously been shown to be strongly expressed by neurons in the central nervous system . The preliminary results from this study appear to show that Na V 1.1 is weakly expressed in the SGN with strong axonal localisation. As dual labelling experiments could not be performed using the Na V 1.1 antibody, we cannot report if Na V 1.1 expression is restricted to the Type I or Type II neurons.
Na V 1.7 subunit expression: Na V 1.7 is considered to be exclusively expressed by neurons in the PNS, especially in the cell bodies show that the Na V 1.7 subtype is expressed in the cell bodies of the rat SGN. In contrast to this rodent model, Na V 1.7 was not reported to be present in the murine model of . This may reflect a species difference in expression of the Na V 1.7 subunit.
Na V 1.6 subunit expression: It has been previously reported that the Na V 1.6 subtype is expressed in murine SGN with Na V 1.6 localised at the initial segment and nodes of Ranvier and not in the cell bodies. The results here in the rat SGN are also partly in line with this earlier study. Na V 1.6 labelling was found in the cell body cytoplasm as well as the processes of the rat SGN. The presence of cytoplasmic labelling in the cell body seen here is in agreement with previous reports of Na V 1.6 labelling in other sensory ganglia . In addition, cytoplasmic labelling has also been reported for potassium channels in the cell bodies of murine SGN and rat DRG neurons . This type of labelling is most likely due to the pooling of subunit proteins in the Golgi apparatus, prior to their transport and insertion into the membrane.
Differential expression of Na V 1.6 and Na V 1.7 in SGN Type 1 and Type II: The measurement of SGN cell body area along with semi-quantitative fluorescence and non-fluorescence imaging techniques enabled the evident variation in labelling intensity to be explored in more detail. Resolution of differential expression was further enhanced by the use of dual labelling with peripherin antibody . The differences in SGN Type 1 and II cell body area have been reported previously and are confirmed by this study .
Whilst reduced fluorescence for both Na V 1.6 and 1.7 was apparent in Type II neurons, the intensity of labelling observed was above background levels, indicating that Type II SGN express these subunits. This would support their possessing some functional capacity.
Currently, little electrophysiological evidence exists to identify the specific role of Type II fibres or that they actually exhibit any acoustically driven activity (Brown, 1994, Robertson, Sellick and , although it has been proposed they may signal static displacement of the basilar membrane .
The difference in cell area between Na V 1.6 and 1.7 expressing Type I neurons may be explained in at least two ways. One hypothesis is that the difference may correlate with signalling function as spontaneous activity in mammalian Type I afferents is known to range between 0-120 spikes sec -1 , which correlates with axon diameter . It would be reasonable to assume that axon diameter also correlates with cell body area and that the expression of Na V 1.6 and 1.7 in Type I SGN may then be related to the spontaneous and/or driven activity of Type I fibres. Alternatively, the differences may simply reflect more intense membranous staining by Na V 1.6 over 1.7. Na V 1.6 has a role in action potential initiation and propagation in many neurons due to its localisation at the axon hillock and nodes of Ranvier, respectively. By contrast Na V 1.7, a channel that shows slow inactivation and stays open in response to slow ramp depolarisations, may have a role in initiating action potential initiation at the hair cell-afferent fibre synapse.
Expression of other Na V isoforms in the SGN:
The expression of other voltage-gated sodium channel isoforms was also investigated in this study. RT-PCR failed to show the expression of mRNA for Na V 1.2, Na V 1.3, Na V 1.8 and Na V 1.9, indicating that these isoforms are not expressed in the rat SGN.
Interestingly, in the murine study by , Na V 1.2 expression in the in the Organ of Corti was observed, but only in the efferent innervation to inner and outer hair cells . The absence of evidence for expression of Na V 1.8 and Na V 1.9
isoforms in this study is in line with earlier observations that TTX completely abolished inward sodium current in isolated SGN . Na V 1.4 and Na V 1.5 expression in the SGN was not studied, as these isoforms are believed to be selectively expressed in skeletal and cardiac muscle respectively .
Control results:
The extensive analysis and comprehensive documentation of the expression of Na V subunits in the CNS and PNS neurons provided positive controls for RT-PCR primers used in the current study. CNS neurons have been shown to express Na V 1.1, Na V 1.2 , Na V 1.3 and Na V 1.6 , and mRNA isolated from the cerebral cortex was used to test the specificity of the RT-PCR primers designed for these Na V subunits. Na V 1.7 and Na V 1.9 were also weakly identified by the RT-PCR primers. While these proteins have not been identified in the cerebral cortex, the mRNA has been detected in this tissue previously . The mRNA isolated from the DRG was used as a positive control to validate the specificity of the RT-PCR primers designed to detect Na V 1.7, Na V 1.8
and Na V 1.9, as the DRG has been previously reported to express these subunits . The RT-PCR primers also identified Na V 1.1 mRNA in the DRG tissues. This result has been reported previously ), but whilst the mRNA for Na V 1.1 has been identified in the DRG, the protein has not been detected in the peripheral nervous system . Both these control tissues yielded results that confirmed that the designed primers were specific for their respective Na V isoforms.
Antibody specificity is necessary for the reliable interpretation of immunohistochemical data.
Sections of rat cochlea without primary antibodies did not display fluorescence specific to the binding of the secondary antibodies to their antigens. However, non-specific cytoplasmic yellow puncta were observed in the SG cell bodies. These results indicate that in the adult rat SGN there are other sources of endogenous fluorescence, possibly lipofuscin. This has also been reported in other adult neural ganglia, including the retina, vestibular and dorsal root ganglion and cerebellar Purkinje cells Fraysse, 1996, Samorajski, Ordy and . Furthermore, we are confident that these puncta were due to nonspecific fluorescence, since we used non-fluorescence DAB/HRP visualisation methods to validate the original results.
Characterising Na V Isoforms in the Auditory pathway-Therapeutic Applications:
The characterisation of Na V isoforms in the periphery of the normal auditory pathway contribute to the development of therapeutics for treating conditions such as tinnitus. The clinical evidence that voltage-gated sodium blockers may have a role in ameliorating certain types of tinnitus is well documented because lignocaine, a use-dependent sodium channel blocker and local anaesthetic, is the gold standard tinnitolytic agent and is effective in around 50% of patients . Following ototrauma, it is apparent that marked plastic changes occur in the auditory pathway some of which have parallels with sensory nerve trauma . In models of neuropathic pain this is accompanied by changes in pattern and expression of Na V subtype and profound changes in neuronal excitability . Several Na V channel subtypes including Na V 1.7 and Na V 1.8 have been implied to regulate spontaneous firing in damaged nociceptive afferents although there is much debate from studies using antisense knock-down methodologies and transgenic animals as to which are the most important (for reviews see Krafte and Bannon, 2008, Momin and Wood, 2008) .
The use of appropriate models of ototrauma would establish whether similar or other changes in Na V isoforms may underlie tinnitus. This would provide the basis for optimal matching of tinnitolytic therapeutics to their tinnitogenic target.
Experimental Methods
RT-PCR
Tissue extraction: Male Wistar rats (250-400g) were sacrificed using Euthanal® (IP) in accordance with UK Home Office Animals Act 1986 (schedule 1). The dorsal root ganglia (DRG) and cerebral cortex were rapidly excised and frozen over dry ice in a sterile RNase/DNase free tube. The temporal bones were removed and excess bone was removed to leave the bony inner ear segment that contained the cochlea. The otic capsule of the cochlea was removed to reveal the modiolus, which was then carefully removed from the remaining bone and frozen over dry ice as above. PCR reaction: The PCR reaction was performed using BIOTAQ DNA polymerase (Bioline, London, UK), custom designed sense and antisense primers at 0.5μM final concentration (Sigma Genosys, Cambridge, UK) and 1μl of cDNA using a T-Gradient Biometra thermocycler (Biotron, Göttingen, Germany). Thirty-five PCR cycles were performed using annealing temperatures between 54 and 59 o C. The PCR products were separated by electrophoresis on a 1% agarose gel with ethidium bromide and a 100 base pair DNA ladder (Promega, Southampton, UK) at 110V. The gel was photographed under ultraviolet illumination using a digital camera and Kodak digital science 1D software (Kodak). The mRNA isolation, cDNA synthesis and PCR reaction was repeated four times, using modioli from a fresh rat each time.
Primer design: Primer pairs specific to the Na V alpha subunits and β-actin used are summarised in table 1. The primer pairs were designed to cross intron-exon boundaries as determined from the rat sequences. This would show any genomic DNA contamination of the PCR products as a higher base pair size band than the calculated band. The identity of PCR products was confirmed by sequencing. 
Tissue preparation for immunohistochemistry
Dorsal root ganglion extraction:
Immunohistochemistry on frozen sections
Antibody information: Information about the primary and secondary antibodies used in this study is presented in table 2. Control experiments were carried out to determine the amount of non-specific binding by omitting the primary antiserum from the incubation media. Pre-incubation of primary antibody with the blocking peptide overnight reduced the labelling to background levels.
For identification of Type II SG neurons, experiments were carried out using an antiperipherin monoclonal antibody MAB 1527 raised in mouse (Millipore, Watford, UK) as this protein is known to be selectively expressed in Type II SG neurons . Figure 1 . Na V mRNA channel expression in adult rat nervous tissues. PCR products were separated by electrophoresis on a 1% agarose gel stained with ethidium bromide. (A) PCR products were detected for Nav1.1, 1.2, 1.3 and 1.6 in the rat cerebral cortex, with weak bands for Na V 1.7 and Na V 1.9. (B) PCR products were detected for Nav1.1, 1.6, 1.7, 1.8 and 1.9 in the rat DRG. (C) PCR products were detected for Nav1.1, 1.6 and 1.7 in the rat SGN. All tissues were positive for β-actin. M lane, 100bp ladder with brightest band representing 500bp . Expected product sizes are given in methods section. PCR was performed either in the presence (+) or absence (-) ofreverse transcription. 
